Tumor-Derived IL33 Promotes Tissue-Resident CD8 + T Cells and Is Required for Checkpoint Blockade Tumor Immunotherapy - Chen, Lujun; Sun, Runzi; Xu, Junchi; Zhai, Wensi; Zhang, Dachuan; Yang, Min; Yue, Cuihua; Chen, Yichao; Li, Song; Turnquist, Heth; Jiang, Jingting; Lu, Binfeng (Cancer immunology research, 2020)
Keywords: Animals; CD8-Positive T-Lymphocytes - immunology; Disease Models, Animal; Humans; Immunotherapy - methods; Interleukin-33 - metabolism; Mice